Yüklüyor......
Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy
Cancer immunotherapy with checkpoint blockade has become standard of care treatment for numerous cancer types. Despite this, robust predictive biomarkers are lacking. There is increasing evidence that the host microbiome is a predictor of immunotherapy response, although the optimal host microbiome...
Kaydedildi:
| Yayımlandı: | J Immunother Cancer |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604862/ https://ncbi.nlm.nih.gov/pubmed/33127655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001383 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|